Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 21, 1996, Pages 11802-11807

  Umekita, Yoshihisa ^a   Hiipakka, Richard A ^a   Kokontis, John M ^a   Liao, Shutsung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 dihydrotestosterone; 5 reductase inhibitor; androgen receptor; cancer cell progression; tumor regression

Indexed keywords

5BETA ANDROSTANOLONE; ANDROSTANOLONE; ESTRADIOL; FINASTERIDE; MEDROXYPROGESTERONE ACETATE; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER REGRESSION; DRUG EFFECT; GROWTH INHIBITION; HORMONE INHIBITION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ANDROGEN-BINDING PROTEIN; ANIMALS; CELL DIVISION; CELL LINE; DIHYDROTESTOSTERONE; DNA PRIMERS; DRUG IMPLANTS; ENZYME INHIBITORS; ESTRADIOL; FINASTERIDE; HUMANS; MALE; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, NUDE; ORCHIECTOMY; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS MUSCULUS;

EID: 0029859580     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.21.11802     Document Type: Article

References (41)

1. Parker, S. L., Tong, T., Bolden, S. & Wingo, P. A. (1996) Ca Cancer J. Clin. 46, 5-27.
2. Huggins, C. & Hodges, C. V. (1941) Cancer Res. 1, 293-297.
3. Dawson, N. A. & Vogelzang, N., eds. (1994) Prostate Cancer (Wiley-Liss, New York).
4. Coffey, D. S. (1993) Cancer 71, 880-886.
5. Geller, J. (1993) Cancer 71, Suppl., 1039-1045.
6. Kokontis, J., Takakura, K., Hay, N. & Liao, S. (1994) Cancer Res. 54, 1566-1573.
7. Thalmann, G. N., Anezinis, P. E., Chang, S., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C. & Chung, L. W. K. (1994) Cancer Res. 54, 2577-2581.
8. Joly-Pharaboz, M.-O., Soave, M.-C., Nicolas, B., Mebarki, F., Renaud, M., Foury, O., Morel, Y. & Andre, J. G. (1995) J. Steroid Biochem. Mol. Biol. 55, 67-76.
9. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M. & Hiipakka, R. A. (1995) Cancer Lett. 96, 239-243.
10. Tilley, W. D., Wilson, C. M., Marcelli, M. & McPhaul, M. J. (1990) Cancer Res. 50, 5382-5386.
11. Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H. & Hittmair, A. (1995) Cancer Res. 55, 3068-3072.
12. Darbre, P. D. & King, R. J. B. (1987) Cell 51, 521-528.
13. Janek, P., Briand, P. & Hartman, N. R. (1975) Cancer Res. 35, 3698-3704.
14. Chomczynski, P. & Sacchi, N. (1987) Anal. Biochem. 162, 156-159.
15. Zinn, K., DiMaio, D. & Maniatis, T. (1983) Cell 34, 865-879.
16. Hay, N., Bishop, J. M. & Levens, D. (1987) Genes Dev. 1, 659-671.
17. Chang, C., Kokontis, J. & Liao, S. (1988) Proc. Natl. Acad. Sci. USA 85, 7211-7215.
18. Young, C. Y.-F., Montgomery, B. T., Andrews, P. E., Qui, S., Bilhartz, D. L. & Tindall, D. J. (1991) Cancer Res. 51, 3748-3752.
19. Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E. & Bishop, J. M. (1983) Proc. Natl. Acad. Sci. USA 80, 1707-1711.
20. Suggs, S. V., Wallace, R. B., Hirose, T., Kawashima, E. H. & Itakura, K. (1981) Proc. Natl. Acad. Sci. USA 78, 6613-6617.
21. Kokontis, J., Ito, K., Hiipakka, R. A. & Liao, S. (1991) Receptor 1, 271-279.
22. Liang, T., Hoyer, S., Yu, R., Soltani, K., Lorinz, A. L., Hiipakka, R. A. & Liao, S. (1993) J. Invest. Dermatol. 100, 663-666.
23. Veldscholte, J., Ris-Stalper, C., Kuiper, G. G. J. M., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C. J., Trapman, J., Brinkman, A. O. & Mulder, E. (1990) Biochem. Biophys. Res. Commun. 173, 534-540.
24. Russell, D. W. & Wilson, J. D. (1994) Annu. Rev. Biochem. 63, 25-61.
25. Bruchovsky, N. & Wilson, J. D. (1968) J. Biol. Chem. 267, 2012-2021.
26. Anderson, K. M. & Liao, S. (1968) Nature (London) 219, 277-279.
27. Yuan, S., Trachtenberg, J., Mills, G. B., Brown, T. J., Xu, F. & Keating, A. (1993) Cancer Res. 53, 1304-1311.
28. Kyprianou, N. & Issacs, J. T. (1989) Mol. Endocrinol. 3, 1515-1522.
29. Wilding, G. (1991) Cancer Surv. 11, 147-163.
30. Kim, I. Y., Kim, J., Zelner, D. J., Ahn, H., Sansibar, J. A. & Lee, C. (1996) Endocrinology 137, 991-999.
31. Bettuzzi, S., Hiipakka, R., Gilna, P. & Liao, S. (1989) Biochem. J. 257, 293-296.
32. Monpetit, M. L., Lawlep, K. R. & Tenniswood, M. (1986) Prostate 8, 25-36.
33. Sensibar, J. A., Sutkowski, D. M., Raffo, A., Buttyan, R., Griswold, M. D., Sylvester, S. R., Kozlowski, J. M. & Lee, C. (1995) Cancer Res. 55, 2431-2437.
34. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W. & Folkman, J. (1993) Am. J. Pathol. 143, 401-409.
35. Goldenberg, S. L., Bruchovsky, N., Gleave, M. E., Sullivan, L. & Akakura, K. (1995) Urology 45, 839-845.
36. Stoner, E. & Finasteride Study Group (1994) Arch. Intern. Med. (Moscow) 154, 83-88.
37. Gormley, G. J., Brawley, O. & Thompson, I. (1995) Ann. N.Y. Acad. Sci. 768, 163-169.
38. Wilding, G., Chen, M. & Gelman, E. P. (1989) Prostate 14, 103-115.
39. Furr, B. J. A. (1995) Ann. N.Y. Acad. Sci. 761, 79-96.
40. Stoll, B. A. (1973) Br. Med. J. 3, 446-450.
41. Fowler, J. E. & Whitmore, W. F. (1981) J. Urol. 126, 372-375.